Your Messages Inbox
Your Article Summary
See Latest ArticlesNovartis successfully launches EUR 1.5 billion notes issue
Novartis, 06/03/09
Novartis has successfully launched a notes issue of EUR 1.5 billion with a coupon of 4.25% under its EUR 15 billion Euro Medium Term Note Programme. Proceeds will be used for general corporate purposes. The seven-year note was priced at 99.757% and has a maturity date of June 2016. It is guaranteed by Novartis AG, which is incorporated in Switzerland and is the ultimate parent company of Novartis Finance S.A., Luxembourg, the issuing entity.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09
Article Search
Sponsor